Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
International Journal of Surgical Pathology|March 24, 2011
Evaluation of prognostic factors and their capacity to predict biological behavior in gastrointestinal stromal tumorsSilvia Calabuig-Fariñas, José Antonio López-Guerrero, Samuel Navarro, et al.
Seminars in Oncology|August 12, 2009
Gastrointestinal stromal tumors II: medical oncology and tumor response assessmentRobert S Benjamin, Maria Debiec-Rychter, Axel Le Cesne, et al.
Scientific Reports|December 4, 2019
Prognostic classification of endometrial cancer using a molecular approach based on a twelve-gene NGS panelRaquel López-Reig, Antonio Fernández-Serra, Ignacio Romero, et al.
Cancer Chemotherapy and Pharmacology|September 7, 2014
GEIS 2013 guidelines for gastrointestinal sarcomas (GIST)Andrés Poveda, Xavier García del Muro, Jose Antonio López-Guerrero, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 14, 2017
Malignant Bowel Obstruction in Relapsed Ovarian Cancer With Peritoneal Carcinomatosis: An Occlusive StatePedro Martinez Castro, Lara Vargas, Antonio Mancheño, et al.
Cancer Treatment Reviews|March 30, 2017
GEIS guidelines for gastrointestinal sarcomas (GIST)Andrés Poveda, Xavier García Del Muro, Jose Antonio López-Guerrero, et al.
Gynecologic Oncology|November 12, 2013
Nibrin is a marker of clinical outcome in patients with advanced serous ovarian cancer treated in the phase III OVA-301 trialBradley J Monk, Stanley B Kaye, Andrés Poveda, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 11, 2017
Resisting RECIST-Uniformity Versus Clinical ValidityMichelle K Wilson, Michael L Friedlander, Stephanie Lheureux, et al.
Histopathology|July 29, 2009
Dermatofibrosarcoma protuberans: clinical, pathological, and genetic (COL1A1-PDGFB ) study with therapeutic implicationsBeatriz Llombart, Onofre Sanmartín, Jose Antonio López-Guerrero, et al.
Journal of the American Academy of Dermatology|May 17, 2011
Dermatofibrosarcoma protuberans: a clinicopathological, immunohistochemical, genetic (COL1A1-PDGFB), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumorsBeatriz Llombart, Carlos Monteagudo, Onofre Sanmartín, et al.
Pageof 6